查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗生素抗藥性市場依疾病（cUTI、cIAI、BSI）、病原體（大腸桿菌、肺炎克雷伯菌）、藥物類別（噁唑烷酮類、頭孢菌素）、作用機轉（細胞壁、蛋白質合成抑制劑）、配銷通路、全球預測, 2023-2032
市場調查報告書
商品編碼
1370609

抗生素抗藥性市場依疾病（cUTI、cIAI、BSI）、病原體（大腸桿菌、肺炎克雷伯菌）、藥物類別（噁唑烷酮類、頭孢菌素）、作用機轉（細胞壁、蛋白質合成抑制劑）、配銷通路、全球預測, 2023-2032

Antibiotic Resistance Market-By Disease (cUTI, cIAI, BSI), Pathogen (E. coli, K. pneumoniae), Drug Class (Oxazolidinones, Cephalosporin), Mechanism of Action (Cell Wall, Protein Synthesis Inhibitors), Distribution Channel, Global Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 212 Pages | 商品交期: 2-3個工作天內

價格

2023年至2032年，抗生素抗藥性市場將以5.3%的年複合成長率成長。濫用抗生素藥物引發的抗藥性細菌的發展正在增加對替代治療方案的需求，推動產業擴張。

此外，全球人口老化，對感染的敏感度更高，正在推動對新型抗生素的需求。醫療保健相關感染的增加和​​多重抗藥性病原體的出現也推動了對新型抗菌藥物研發的投資，以對抗抗生素抗藥性。

政府措施、監管激勵措施以及對抗生素抗藥性威脅的認知的提高將進一步促進市場擴張。 2022 年11 月，聯合國糧農組織、環境署、世界動物衛生組織和世界衛生組織宣布了一項名為「抗菌素抗藥性多利益攸關方夥伴關係平台」的新舉措，以解決抗菌素抗藥性對全球人口日益嚴重的影響。鑑於對創新解決方案的迫切需求，抗生素抗藥性產業將在未來幾年大幅擴張。

市場根據疾病、病原體、藥物類別、作用機制、配銷通路和地區進行分類。

根據疾病情況，從2023 年到2032 年，血流感染領域的年複合成長率將達到5%。敗血症和血流感染盛行率的不斷上升、醫療保健相關病例的增加以及重症監護環境中抗生素耐藥病原體日益嚴峻的挑戰將推動成長在段中。

到 2032 年，銅綠假單胞菌病原體部分的年複合成長率將達到 6.5%，這是由病原體對多種抗生素的廣泛抗藥性等因素推動的，這推動了對替代治療的需求。醫療機構中銅綠假單胞菌感染發生率的上升也將促進該領域的成長。

由於頭孢菌素抗藥性菌株的盛行率不斷上升，頭孢菌素藥物類別在 2023 年至 2032 年間將呈現 6.1% 的年複合成長率，這將需要開發新的有效治療方法。醫療保健相關感染負擔的不斷增加以及對創新抗菌藥物的需求也將促進該領域的成長。

從地區來看，到 2032 年，亞太地區抗生素抗藥性產業的年複合成長率將達到 5.8%，受到該地區醫療保健普及、人口密度和抗菌藥物濫用等因素的推動。隨著該地區應對抗生素抗藥性挑戰，意識的提高、政府措施和經濟發展將進一步推動產業擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：抗生素抗藥性市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 抗生素抗藥性感染發生率增加
      • 對新抗生素療法的需求不斷成長
      • 加大新型抗生素研發投入
      • 提高全球公共衛生關注和意識
    • 產業陷阱與挑戰
      • 治療費用高
      • 複雜的監管和開發過程
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：抗生素抗藥性市場估計與預測：按疾病分類

  • 主要動向：按疾病
  • 複雜性泌尿道感染
  • 複雜性腹腔內感染
  • 血流感染
  • 急性細菌性皮膚和皮膚結構感染
  • 社區型細菌性肺炎
  • 艱難梭菌感染
  • 醫院獲得性細菌性肺炎

第 6 章：抗生素抗藥性市場估計與預測：按病原體

  • 主要動向：依病原體
  • 大腸桿菌
  • 肺炎克雷伯菌
  • 銅綠假單胞菌
  • 金黃色葡萄球菌
  • 鮑曼氏菌
  • 肺炎鏈球菌
  • 流感嗜血桿菌
  • 艱難梭菌
  • 屎腸球菌

第 7 章：抗生素抗藥性市場估計與預測：按藥物類別

  • 主要動向：依藥物類別
  • 噁唑烷酮類
  • 頭孢菌素
  • 脂糖肽
  • 聯合療法
  • 四環素類
  • 其他藥物類別

第 8 章：抗生素抗藥性市場估計與預測：按作用機制

  • 主要動向：按作用機制
  • 細胞壁合成抑制劑
  • 蛋白質合成抑制劑
  • DNA合成抑制劑
  • RNA合成抑制劑
  • 其他作用機制

第 9 章：抗生素抗藥性市場估計與預測：按配銷通路

  • 主要動向：按配銷通路
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 10 章：抗生素抗藥性市場估計與預測：按地區

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 瑞士
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 11 章：公司簡介

  • ACHAOGEN, INC.
  • Basilea Pharmaceutica Ltd.
  • MELINTA THERAPEUTICS
  • Tetraphase Pharmaceuticals, Inc.
  • Theravance Biopharma
  • WOCKHARDT
  • Entasis therapeutics
  • Paratek Pharmaceuticals, Inc.
  • Seres Therapeutics
  • AbbVie, Inc.
  • Merck & Co. Inc.
  • Pfizer Inc.
Product Code: 6499

The antibiotic resistance market will grow with 5.3% CAGR from 2023 to 2032. The development of drug-resistant bacteria triggered by misuse of antibiotic medications is increasing the demand for alternative treatment options, propelling industry expansion.

Additionally, the aging global population, with a higher susceptibility to infections, is driving the need for novel antibiotics. Rising healthcare-associated infections and the emergence of multi-drug-resistant pathogens have also fueled investments in research and development of new antimicrobial agents to combat antibiotic resistance.

Government initiatives, regulatory incentives, and increased awareness about the threat of antibiotic resistance will further contribute to market expansion. In November 2022, the UN's FAO, UNEP, the World Organization for Animal Health, and the WHO announced a new initiative called the Antimicrobial Resistance Multi-Stakeholder Partnership Platform to address the escalating implications of antimicrobial resistance on the global population. Given the pressing need for innovative solutions, the antibiotic resistance industry will expand significantly in the coming years.

The market is segregated based on disease, pathogen, drug class, mechanism of action, distribution channel, and region.

Based on disease, the bloodstream infection segment will exhibit a 5% CAGR from 2023 to 2032. The increasing prevalence of sepsis and bloodstream infections, rising healthcare-associated cases, and the growing challenge of antibiotic-resistant pathogens in critical care settings will drive growth in the segment.

The P. aeruginosa pathogen segment will reflect a 6.5% CAGR through 2032, driven by factors such as the pathogen's widespread resistance to multiple antibiotics, which is driving the demand for alternative treatments. The rising incidences of P. aeruginosa infections in healthcare settings will also foster growth in the segment.

The cephalosporin drug class segment will exhibit 6.1% CAGR between 2023 and 2032, driven by the escalating prevalence of cephalosporin-resistant bacterial strains, which will necessitate the development of new and effective treatments. The rising burden of healthcare-associated infections and demand for innovative antimicrobial agents will also augment growth in the segment.

Regionally, the Asia Pacific antibiotic resistance industry will witness a 5.8% CAGR through 2032, driven by factors such as increasing healthcare access, population density, and antimicrobial misuse in the region. Rising awareness, government initiatives, and economic development will further drive industry expansion as the region addresses antibiotic resistance challenges.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Antibiotic resistance industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Disease trends
    • 2.1.4 Pathogen trends
    • 2.1.5 Drug class trends
    • 2.1.6 Mechanism of action trends
    • 2.1.7 Distribution channel trends

Chapter 3 Antibiotic Resistance Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of antibiotic resistant infections
      • 3.2.1.2 Growing need for new antibiotic therapies
      • 3.2.1.3 Increasing investment for research and development of novel antibiotics
      • 3.2.1.4 Increasing global public health concern and awareness
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of therapeutics
      • 3.2.2.2 Complex regulatory and development process
  • 3.3 Growth potential analysis
    • 3.3.1 By disease
    • 3.3.2 By pathogen
    • 3.3.3 By drug class
    • 3.3.4 By mechanism of action
    • 3.3.5 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic dashboard, 2022

Chapter 5 Antibiotic Resistance Market Estimates and Forecast, By Disease (USD Million)

  • 5.1 Key trends, by disease
  • 5.2 Complicated urinary tract infections
  • 5.3 Complicated intra-abdominal infections
  • 5.4 Bloodstream infection
  • 5.5 Acute bacterial skin and skin-structure infection
  • 5.6 Community-acquired bacterial pneumonia
  • 5.7 Clostridium difficile infections
  • 5.8 Hospital-acquired bacterial pneumonia

Chapter 6 Antibiotic Resistance Market Estimates and Forecast, By Pathogen (USD Million)

  • 6.1 Key trends, by pathogen
  • 6.2 E. coli
  • 6.3 K. pneumoniae
  • 6.4 P. aeruginosa
  • 6.5 S. aureus
  • 6.6 Baumannii
  • 6.7 S. pneumoniae
  • 6.8 H. influenzae
  • 6.9 C. difficile
  • 6.10 E. faecium

Chapter 7 Antibiotic Resistance Market Estimates and Forecast, By Drug Class (USD Million)

  • 7.1 Key trends, by drug class
  • 7.2 Oxazolidinones
  • 7.3 Cephalosporin
  • 7.4 Lipoglycopeptides
  • 7.5 Combination therapies
  • 7.6 Tetracyclines
  • 7.7 Other drug classes

Chapter 8 Antibiotic Resistance Market Estimates and Forecast, By Mechanism of Action (USD Million)

  • 8.1 Key trends, by mechanism of action
  • 8.2 Cell wall synthesis inhibitors
  • 8.3 Protein synthesis inhibitors
  • 8.4 DNA synthesis inhibitors
  • 8.5 RNA synthesis inhibitors
  • 8.6 Other mechanism of actions

Chapter 9 Antibiotic Resistance Market Estimates and Forecast, By Distribution Channel (USD Million)

  • 9.1 Key trends, by distribution channel
  • 9.2 Hospital pharmacies
  • 9.3 Retail pharmacies
  • 9.4 Online pharmacies

Chapter 10 Antibiotic Resistance Market Estimates and Forecast, By Region (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Switzerland
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 ACHAOGEN, INC.
  • 11.2 Basilea Pharmaceutica Ltd.
  • 11.3 MELINTA THERAPEUTICS
  • 11.4 Tetraphase Pharmaceuticals, Inc.
  • 11.5 Theravance Biopharma
  • 11.6 WOCKHARDT
  • 11.7 Entasis therapeutics
  • 11.8 Paratek Pharmaceuticals, Inc.
  • 11.9 Seres Therapeutics
  • 11.10 AbbVie, Inc.
  • 11.11 Merck & Co. Inc.
  • 11.12 Pfizer Inc.

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by disease (2022)
  • TABLE 3 Market revenue, by pathogen (2022)
  • TABLE 4 Market revenue, by drug class (2022)
  • TABLE 5 Market revenue, by mechanism of action (2022)
  • TABLE 6 Market revenue, by distribution channel (2022)
  • TABLE 7 Market share, by region (2022)
  • TABLE 8 Global antibiotic resistance market size, by region, 2018 - 2022 (USD Million)
  • TABLE 9 Global antibiotic resistance market size, by region, 2023 - 2032 (USD Million)
  • TABLE 10 Global antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 11 Global antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 12 Global antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 13 Global antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 14 Global antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 15 Global antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 16 Global antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 17 Global antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 18 Global antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 19 Global antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 20 Industry impact forces
  • TABLE 21 Competitive benchmarking of major market players
  • TABLE 22 Competitive positioning matrix: Classification criteria
  • TABLE 23 Strategic outlook matrix: Classification criteria
  • TABLE 24 Complicated urinary tract infections market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25 Complicated urinary tract infections market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Complicated intra-abdominal infections market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Complicated intra-abdominal infections market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Bloodstream infection market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Bloodstream infection market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Acute bacterial skin and skin-structure infection market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Acute bacterial skin and skin-structure infection market size, by region, 2023 - 2032 (USD Million)
  • TABLE 32 Community-acquired bacterial pneumonia market size, by region, 2018 - 2022 (USD Million)
  • TABLE 33 Community-acquired bacterial pneumonia market size, by region, 2023 - 2032 (USD Million)
  • TABLE 34 Clostridium difficile infections market size, by region, 2018 - 2022 (USD Million)
  • TABLE 35 Clostridium difficile infections market size, by region, 2023 - 2032 (USD Million)
  • TABLE 36 Hospital-acquired bacterial pneumonia market size, by region, 2018 - 2022 (USD Million)
  • TABLE 37 Hospital-acquired bacterial pneumonia market size, by region, 2023 - 2032 (USD Million)
  • TABLE 38 E. coli market size, by region, 2018 - 2022 (USD Million)
  • TABLE 39 E. coli market size, by region, 2023 - 2032 (USD Million)
  • TABLE 40 K. pneumoniae market size, by region, 2018 - 2022 (USD Million)
  • TABLE 41 K. pneumoniae market size, by region, 2023 - 2032 (USD Million)
  • TABLE 42 P. aeruginosa market size, by region, 2018 - 2022 (USD Million)
  • TABLE 43 P. aeruginosa market size, by region, 2023 - 2032 (USD Million)
  • TABLE 44 S. aureus market size, by region, 2018 - 2022 (USD Million)
  • TABLE 45 S. aureus market size, by region, 2023 - 2032 (USD Million)
  • TABLE 46 Baumannii market size, by region, 2018 - 2022 (USD Million)
  • TABLE 47 Baumannii market size, by region, 2023 - 2032 (USD Million)
  • TABLE 48 S. pneumoniae market size, by region, 2018 - 2022 (USD Million)
  • TABLE 49 S. pneumoniae market size, by region, 2023 - 2032 (USD Million)
  • TABLE 50 H. influenzae market size, by region, 2018 - 2022 (USD Million)
  • TABLE 51 H. influenzae market size, by region, 2023 - 2032 (USD Million)
  • TABLE 52 C. difficile market size, by region, 2018 - 2022 (USD Million)
  • TABLE 53 C. difficile market size, by region, 2023 - 2032 (USD Million)
  • TABLE 54 E. faecium market size, by region, 2018 - 2022 (USD Million)
  • TABLE 55 E. faecium market size, by region, 2023 - 2032 (USD Million)
  • TABLE 56 Oxazolidinones market size, by region, 2018 - 2022 (USD Million)
  • TABLE 57 Oxazolidinones market size, by region, 2023 - 2032 (USD Million)
  • TABLE 58 Cephalosporin market size, by region, 2018 - 2022 (USD Million)
  • TABLE 59 Cephalosporin market size, by region, 2023 - 2032 (USD Million)
  • TABLE 60 Lipoglycopeptides market size, by region, 2018 - 2022 (USD Million)
  • TABLE 61 Lipoglycopeptides market size, by region, 2023 - 2032 (USD Million)
  • TABLE 62 Combination therapies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 63 Combination therapies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 64 Tetracyclines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 65 Tetracyclines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 66 Other drug classes market size, by region, 2018 - 2022 (USD Million)
  • TABLE 67 Other drug classes market size, by region, 2023 - 2032 (USD Million)
  • TABLE 68 Cell wall synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 69 Cell wall synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 70 Protein synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 71 Protein synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 72 DNA synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 73 DNA synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 74 RNA synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 75 RNA synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 76 Other mechanism of actions market size, by region, 2018 - 2022 (USD Million)
  • TABLE 77 Other mechanism of actions market size, by region, 2023 - 2032 (USD Million)
  • TABLE 78 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 79 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 80 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 81 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 82 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 83 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 84 North America antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
  • TABLE 85 North America antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
  • TABLE 86 North America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 87 North America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 88 North America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 89 North America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 90 North America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 91 North America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 92 North America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 93 North America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 94 North America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 95 North America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 96 U.S. antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 97 U.S. antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 98 U.S. antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 99 U.S. antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 100 U.S. antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 101 U.S. antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 102 U.S. antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 103 U.S. antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 104 U.S. antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 105 U.S. antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 106 Canada antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 107 Canada antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 108 Canada antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 109 Canada antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 110 Canada antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 111 Canada antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 112 Canada antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 113 Canada antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 114 Canada antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 115 Canada antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 116 Europe antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
  • TABLE 117 Europe antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
  • TABLE 118 Europe antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 119 Europe antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 120 Europe antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 121 Europe antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 122 Europe antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 123 Europe antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 124 Europe antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 125 Europe antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 126 Europe antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 127 Europe antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 128 Germany antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 129 Germany antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 130 Germany antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 131 Germany antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 132 Germany antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 133 Germany antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 134 Germany antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 135 Germany antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 136 Germany antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 137 Germany antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 138 UK antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 139 UK antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 140 UK antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 141 UK antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 142 UK antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 143 UK antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 144 UK antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 145 UK antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 146 UK antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 147 UK antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 148 France antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 149 France antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 150 France antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 151 France antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 152 France antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 153 France antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 154 France antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 155 France antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 156 France antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 157 France antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 158 Spain antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 159 Spain antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 160 Spain antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 161 Spain antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 162 Spain antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 163 Spain antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 164 Spain antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 165 Spain antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 166 Spain antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 167 Spain antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 168 Italy antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 169 Italy antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 170 Italy antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 171 Italy antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 172 Italy antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 173 Italy antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 174 Italy antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 175 Italy antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 176 Italy antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 177 Italy antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 178 Switzerland antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 179 Switzerland antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 180 Switzerland antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 181 Switzerland antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 182 Switzerland antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 183 Switzerland antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 184 Switzerland antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 185 Switzerland antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 186 Switzerland antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 187 Switzerland antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 188 Rest of Europe antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 189 Rest of Europe antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 190 Rest of Europe antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 191 Rest of Europe antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 192 Rest of Europe antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 193 Rest of Europe antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 194 Rest of Europe antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 195 Rest of Europe antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 196 Rest of Europe antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 197 Rest of Europe antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 198 Asia Pacific antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
  • TABLE 199 Asia Pacific antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
  • TABLE 200 Asia Pacific antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 201 Asia Pacific antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 202 Asia Pacific antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 203 Asia Pacific antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 204 Asia Pacific antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 205 Asia Pacific antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 206 Asia Pacific antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 207 Asia Pacific antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 208 Asia Pacific antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 209 Asia Pacific antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 210 China antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 211 China antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 212 China antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 213 China antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 214 China antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 215 China antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 216 China antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 217 China antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 218 China antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 219 China antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 220 Japan antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 221 Japan antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 222 Japan antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 223 Japan antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 224 Japan antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 225 Japan antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 226 Japan antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 227 Japan antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 228 Japan antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 229 Japan antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 230 India antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 231 India antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 232 India antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 233 India antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 234 India antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 235 India antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 236 India antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 237 India antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 238 India antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 239 India antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 240 Australia antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 241 Australia antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 242 Australia antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 243 Australia antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 244 Australia antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 245 Australia antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 246 Australia antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 247 Australia antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 248 Australia antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 249 Australia antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 250 South Korea antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 251 South Korea antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 252 South Korea antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 253 South Korea antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 254 South Korea antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 255 South Korea antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 256 South Korea antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 257 South Korea antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 258 South Korea antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 259 South Korea antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 260 Rest of Asia Pacific antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 261 Rest of Asia Pacific antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 262 Rest of Asia Pacific antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 263 Rest of Asia Pacific antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 264 Rest of Asia Pacific antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 265 Rest of Asia Pacific antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 266 Rest of Asia Pacific antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 267 Rest of Asia Pacific antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 268 Rest of Asia Pacific antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 269 Rest of Asia Pacific antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 270 Latin America antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
  • TABLE 271 Latin America antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
  • TABLE 272 Latin America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 273 Latin America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 274 Latin America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 275 Latin America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 276 Latin America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 277 Latin America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 278 Latin America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 279 Latin America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 280 Latin America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 281 Latin America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 282 Brazil antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 283 Brazil antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 284 Brazil antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 285 Brazil antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 286 Brazil antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 287 Brazil antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 288 Brazil antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 289 Brazil antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 290 Brazil antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 291 Brazil antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 292 Mexico antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 293 Mexico antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 294 Mexico antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 295 Mexico antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 296 Mexico antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 297 Mexico antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 298 Mexico antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 299 Mexico antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 300 Mexico antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 301 Mexico antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 302 Rest of Latin America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 303 Rest of Latin America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 304 Rest of Latin America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 305 Rest of Latin America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 306 Rest of Latin America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 307 Rest of Latin America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 308 Rest of Latin America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 309 Rest of Latin America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 310 Rest of Latin America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 311 Rest of Latin America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 312 Middle East & Africa antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
  • TABLE 313 Middle East & Africa antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
  • TABLE 314 Middle East & Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 315 Middle East & Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 316 Middle East & Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 317 Middle East & Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 318 Middle East & Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 319 Middle East & Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 320 Middle East & Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 321 Middle East & Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 322 Middle East & Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 323 Middle East & Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 324 South Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 325 South Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 326 South Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 327 South Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 328 South Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 329 South Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 330 South Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 331 South Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 332 South Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 333 South Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 334 Saudi Arabia antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 335 Saudi Arabia antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 336 Saudi Arabia antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 337 Saudi Arabia antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 338 Saudi Arabia antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 339 Saudi Arabia antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 340 Saudi Arabia antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 341 Saudi Arabia antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 342 Saudi Arabia antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 343 Saudi Arabia antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 344 Rest of Middle East & Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 345 Rest of Middle East & Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 346 Rest of Middle East & Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
  • TABLE 347 Rest of Middle East & Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
  • TABLE 348 Rest of Middle East & Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 349 Rest of Middle East & Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 350 Rest of Middle East & Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
  • TABLE 351 Rest of Middle East & Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
  • TABLE 352 Rest of Middle East & Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 353 Rest of Middle East & Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast methodology
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Antibiotic resistance industry 360 degree synopsis, 2018 - 2032
  • FIG. 7 Growth potential analysis, by disease
  • FIG. 8 Growth potential analysis, by pathogen
  • FIG. 9 Growth potential analysis, by drug class
  • FIG. 10 Growth potential analysis, by mechanism of action
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2022
  • FIG. 15 Competitive positioning matrix, 2022
  • FIG. 16 Strategic dashboard, 2022